PEPTONIC medical AB (publ) (FRA:28L)
Germany · Delayed Price · Currency is EUR 0.0002
0.00 (0.00%)
At close: Nov 28, 2025
PEPTONIC medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 15.69 | 26.89 | 37.12 | 43.63 | 31.64 | 21.28 | Upgrade | |
Revenue Growth (YoY) | -46.32% | -27.55% | -14.93% | 37.90% | 48.68% | 382.77% | Upgrade |
Cost of Revenue | 5.34 | 11.73 | 20.82 | 20.24 | 12.57 | 8.19 | Upgrade |
Gross Profit | 10.35 | 15.16 | 16.3 | 23.4 | 19.07 | 13.09 | Upgrade |
Selling, General & Admin | 41.55 | 56.72 | 52.28 | 56.11 | 65.12 | 41.87 | Upgrade |
Other Operating Expenses | -8.38 | -7.64 | -1.06 | -2.6 | 0.61 | -1.01 | Upgrade |
Operating Expenses | 57.55 | 73.81 | 57.48 | 57 | 92.79 | 44.14 | Upgrade |
Operating Income | -47.19 | -58.65 | -41.19 | -33.61 | -73.72 | -31.05 | Upgrade |
Interest Expense | -1.84 | -1.41 | -2.32 | -5.56 | -0.07 | -0.28 | Upgrade |
Interest & Investment Income | 0.06 | 0.03 | 0.92 | 2.31 | 0.1 | - | Upgrade |
Other Non Operating Income (Expenses) | - | - | 0 | - | -0 | - | Upgrade |
Pretax Income | -48.98 | -60.03 | -42.59 | -36.86 | -73.69 | -31.33 | Upgrade |
Income Tax Expense | - | - | - | - | - | -0.24 | Upgrade |
Net Income | -48.98 | -60.03 | -42.59 | -36.86 | -73.69 | -31.09 | Upgrade |
Net Income to Common | -48.98 | -60.03 | -42.59 | -36.86 | -73.69 | -31.09 | Upgrade |
Shares Outstanding (Basic) | 7,530 | 3,600 | 1,535 | 243 | 192 | 163 | Upgrade |
Shares Outstanding (Diluted) | 7,530 | 3,600 | 1,535 | 243 | 192 | 163 | Upgrade |
Shares Change (YoY) | 30.83% | 134.57% | 532.29% | 26.67% | 17.63% | 17.94% | Upgrade |
EPS (Basic) | -0.01 | -0.02 | -0.03 | -0.15 | -0.38 | -0.19 | Upgrade |
EPS (Diluted) | -0.01 | -0.02 | -0.03 | -0.15 | -0.38 | -0.19 | Upgrade |
Free Cash Flow | -23.81 | -37.56 | -34.45 | -40.22 | -43.36 | -45.86 | Upgrade |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.17 | -0.23 | -0.28 | Upgrade |
Gross Margin | 65.96% | 56.38% | 43.90% | 53.62% | 60.27% | 61.50% | Upgrade |
Operating Margin | -300.71% | -218.10% | -110.96% | -77.02% | -232.97% | -145.91% | Upgrade |
Profit Margin | -312.09% | -223.23% | -114.74% | -84.47% | -232.87% | -146.09% | Upgrade |
Free Cash Flow Margin | -151.69% | -139.66% | -92.82% | -92.17% | -137.04% | -215.46% | Upgrade |
EBITDA | -45.26 | -56.4 | -39.62 | -32.91 | -49.61 | -30.47 | Upgrade |
EBITDA Margin | -288.40% | -209.72% | -106.75% | -75.41% | -156.78% | -143.15% | Upgrade |
D&A For EBITDA | 1.93 | 2.25 | 1.56 | 0.7 | 24.11 | 0.59 | Upgrade |
EBIT | -47.19 | -58.65 | -41.19 | -33.61 | -73.72 | -31.05 | Upgrade |
EBIT Margin | - | -218.10% | -110.96% | -77.02% | -232.97% | -145.91% | Upgrade |
Revenue as Reported | 17.21 | 27.62 | 38.27 | 46.4 | 32.27 | 22.43 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.